HKBU

HKBU-led research identifies Arctic amplification as cause for dust reduction and suggests sustained anti-desertification measures

Retrieved on: 
Tuesday, March 26, 2024
Temperature, Projection, Environment, Public, Climate, Research, United Nations, Sand, Food security, Bacteria, University, Doctor of Philosophy, Anomaly, Wind, Carbon, Dust, Hong Kong Baptist University, Policy, HKBU, Agriculture

In arid regions, strong winds can create high levels of dust aerosols—a mixture of dust, salt, bacteria, and toxic metals—that pollute the environment.

Key Points: 
  • In arid regions, strong winds can create high levels of dust aerosols—a mixture of dust, salt, bacteria, and toxic metals—that pollute the environment.
  • However, the research team's analysis suggested that atmospheric circulation changes related to Arctic amplification is the primary factor that accounts for this condition.
  • Arctic amplification refers to the phenomenon where the Arctic region experiences warming at a faster rate than the rest of the planet.
  • "As the implementation of relevant measures against global warming is mandatory, our research results remind us not to overlook the risks of dust.

HKBU-led research identifies Arctic amplification as cause for dust reduction and suggests sustained anti-desertification measures

Retrieved on: 
Tuesday, March 26, 2024
Temperature, Projection, Environment, Public, Climate, Research, United Nations, Sand, Food security, Bacteria, University, Doctor of Philosophy, Anomaly, Wind, Carbon, Dust, Multimedia, Hong Kong Baptist University, Policy, HKBU, Agriculture

In arid regions, strong winds can create high levels of dust aerosols—a mixture of dust, salt, bacteria, and toxic metals—that pollute the environment.

Key Points: 
  • In arid regions, strong winds can create high levels of dust aerosols—a mixture of dust, salt, bacteria, and toxic metals—that pollute the environment.
  • However, the research team's analysis suggested that atmospheric circulation changes related to Arctic amplification is the primary factor that accounts for this condition.
  • Arctic amplification refers to the phenomenon where the Arctic region experiences warming at a faster rate than the rest of the planet.
  • "As the implementation of relevant measures against global warming is mandatory, our research results remind us not to overlook the risks of dust.

HKBU research suggests potential of artemisinin derivative in treating human obesity

Retrieved on: 
Thursday, March 7, 2024
Liver, School, Liraglutide, Metformin, SCM, GDF15, HKBU, Artesunate, Multimedia, Research, Blood, Obesity, FDA, Fatty liver disease, Exercise, Nausea, Food, GDNF, Trial of the century, Health, Human, Safety, GFRAL, Associate, Patient, Fasting, Insulin, Nature Communications, Tissue, Appetite, Hong Kong Baptist University, Mouse, Public, Pharmaceutical industry

This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.

Key Points: 
  • This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.
  • However, patient compliance with exercise and dietary changes is often challenging, and many anti-obesity drugs are associated with adverse effects.
  • The researchers explored the therapeutic effect of artesunate on obesity using mice with diet-induced obesity.
  • "The research results provide hope for developing a novel treatment agent in response to the public health challenge of obesity, which warrants more extensive and effective interventions," he added.

HKBU research suggests potential of artemisinin derivative in treating human obesity

Retrieved on: 
Thursday, March 7, 2024
Liver, School, Liraglutide, Metformin, SCM, GDF15, HKBU, Artesunate, Research, Blood, Obesity, FDA, Fatty liver disease, Exercise, Nausea, Food, GDNF, Trial of the century, Health, Human, Safety, GFRAL, Associate, Patient, Fasting, Insulin, Nature Communications, Tissue, Appetite, Hong Kong Baptist University, Mouse, Public, Pharmaceutical industry

This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.

Key Points: 
  • This is the first time that artesunate is demonstrated to be able to treat obesity in a non-human primate, suggesting its therapeutic potential as a drug for treating human obesity.
  • However, patient compliance with exercise and dietary changes is often challenging, and many anti-obesity drugs are associated with adverse effects.
  • The researchers explored the therapeutic effect of artesunate on obesity using mice with diet-induced obesity.
  • "The research results provide hope for developing a novel treatment agent in response to the public health challenge of obesity, which warrants more extensive and effective interventions," he added.

New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA

Retrieved on: 
Wednesday, January 10, 2024
Fruit, Patient, Rosaceae, Research, Facial muscles, Associate, Delayed onset muscle soreness, BAG3, Carica, Hong Kong Baptist University, Muscular dystrophy, Myopathy, Disability studies, Prescription, HKBU, Traditional Chinese medicine, Disease, Safety, FDA, Pain, Caricaceae, Investigational New Drug, Agonal respiration, Cardiomyopathy, Paralysis, Muscle atrophy, Pharmaceutical industry

The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.

Key Points: 
  • The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.
  • The research team plans to submit an Investigational New Drug application to FDA in two years to conduct clinical trials.
  • Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Centre for Chinese Herbal Medicine Drug Development at HKBU, said: "CDD-2107 is the fruit of the integration of Chinese medicine theory and modern technology.
  • Receiving the orphan drug designation by FDA for CDD-2107 is an encouraging milestone and recognition of our team's dedication to scientific innovation."

New Chinese medicine drug developed by HKBU for myofibrillar myopathy granted orphan drug designation by FDA

Retrieved on: 
Wednesday, January 10, 2024
Fruit, Patient, Rosaceae, Research, Facial muscles, Associate, Delayed onset muscle soreness, BAG3, Carica, Multimedia, Hong Kong Baptist University, Muscular dystrophy, Myopathy, Disability studies, Prescription, HKBU, Traditional Chinese medicine, Disease, Safety, FDA, Pain, Caricaceae, Investigational New Drug, Agonal respiration, Cardiomyopathy, Paralysis, Muscle atrophy, Pharmaceutical industry

The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.

Key Points: 
  • The drug has obtained the orphan drug designation from the US Food and Drug Administration (FDA), and is the first botanical drug in Hong Kong to receive this qualification.
  • The research team plans to submit an Investigational New Drug application to FDA in two years to conduct clinical trials.
  • Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Centre for Chinese Herbal Medicine Drug Development at HKBU, said: "CDD-2107 is the fruit of the integration of Chinese medicine theory and modern technology.
  • Receiving the orphan drug designation by FDA for CDD-2107 is an encouraging milestone and recognition of our team's dedication to scientific innovation."

Healthcare Week boon for medical industry

Retrieved on: 
Thursday, May 18, 2023
Well, HKCEC, HKUST, HKU, Eye, Robotics, Transport, Chair, Communications and Information Technology Commission (Saudi Arabia), Convention center, Ageing, Hope, Innovation, Technology and Industry Bureau, Research, Government, Computer, Limited, HKTDC, HKBU, Hong Kong Trade Development Council Trade Fairs, Drug discovery, GSK, Health, Hong Kong International Medical Devices and Supplies Fair, Health care, Medicine, Plenary session, History, Global Health, Drawing, Cyberport, MOU, CUHK, ITC, Workforce, Activity, University, HKSAR, Woman, COVID, Polytechnic, Guangdong–Hong Kong–Macao Greater Bay Area, CBE, Summit, HK, Tutoring, Management, Tourism, Pharmaceutical industry, Creative industries, Fair, D

Two flagship events attract global healthcare elites, affirming confidence for Hong Kong's stronger role in the medical and healthcare sector in the region

Key Points: 
  • Two flagship events attract global healthcare elites, affirming confidence for Hong Kong's stronger role in the medical and healthcare sector in the region
    HONG KONG, May 18, 2023 - (ACN Newswire) - Global healthcare sector leaders streamed into Hong Kong for the second International Healthcare Week, organised by the Hong Kong Trade Development Council (HKTDC).
  • "The strong support from the healthcare industry for the Healthcare Week is overwhelming.
  • It has created synergies for medical and healthcare industry professionals and unleashed Hong Kong's strengths in upstream and downstream healthcare industries, Hong Kong is ready to play a bigger role in the medical and healthcare fields in the region," Dr Lam added.
  • A number of content-rich events, including the highly anticipated HKMHDIA Medical Fair Forum, were held during the Medical Fair with keen participation from industry professionals.

Hong Kong Baptist University School of Business Marks 65th Anniversary with Multiple Awards

Retrieved on: 
Tuesday, May 31, 2022
Department, AACSB, MIM, Education, Business administration, HKBU, AIS, Ethics, Environment, School, Learning, Accreditation, Association, Research, SAR, European Foundation, Information system, Decision Sciences, Female, Information, European Quality in Social Services, AMBA, The Apache Software Foundation, EQUIS, Finance, Management development, Association for Information Systems, KONG, Business, Publication, Management, Science

HONG KONG SAR - Media OutReach - 31 May 2022 - The Hong Kong Baptist University (HKBU) School of Business has received noteworthy achievements in conjunction with its 65th anniversary, most recently having been re-accredited by the European Quality Improvement System (EQUIS) for a further five years, the maximum term possible.

Key Points: 
  • HONG KONG SAR - Media OutReach - 31 May 2022 - The Hong Kong Baptist University (HKBU) School of Business has received noteworthy achievements in conjunction with its 65th anniversary, most recently having been re-accredited by the European Quality Improvement System (EQUIS) for a further five years, the maximum term possible.
  • HKBU School of Business was applauded for the excellence of its environment, career support, research-based teaching and whole-person approach to education.
  • The School is one of only 44 business schools in Asia and 108 schools worldwide to hold a triple accreditation from the three main accrediting bodies EQUIS, AACSB and AMBA.
  • Also in its 65th anniversary year, the School achieved a global top 100 ranking for its Master of Science in Business Management (MScBM) programme by the Financial Times Masters in Management (MiM) ranking.

Global Fitness App (Exercise & Weight Loss, Activity Tracking) Market Size, Share, Trends Analysis & Forecast Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 23, 2021
Health, Sports, Football, Technology, Fitness & Nutrition, Mobile, Wireless, Software, Chinese University of Hong Kong, Apple Store, DeMarcus Ware, Asia, Adoption, Diabetes, CAGR, Awareness, Health, Prevalence, Cancer, HealthifyMe, Degenerative disease, CUHK, COVID-19, Korea Disease Control and Prevention Agency, Weight loss, Investment, NFL, Obesity, National Football League, Duke Diet and Fitness Center, Android, Center, HKBU, IOS, Stroke, Mobile phone, Video game

Rising health and fitness awareness and the growing prevalence of obesity are major factors driving the global market.

Key Points: 
  • Rising health and fitness awareness and the growing prevalence of obesity are major factors driving the global market.
  • This, in turn, is fueling the adoption of fitness apps to manage weight and aid weight loss.
  • For instance, HealthifyMe, an Indian fitness app, witnessed a 30% increase in traffic and a 40% increase in revenue in April 2020.
  • In December 2020, National Football League player DeMarcus Ware introduced his fitness app Driven to Win in the Apple Store.

HKBU MSc in Business Management ranked in world's top 100 ranking by Financial Times for the third time

Retrieved on: 
Wednesday, September 15, 2021
School, Business, Knowledge, EQUIS, Achievement, Education, Sustainable Development Goal 4, Student, QS, Doctor of Philosophy, Female, Business administration, LinkedIn, HKBU, DBA, Financial Times, AACSB, Master of Science, Time, MBA, AMBA, Learning, Times Higher Education, Guangdong-Hong Kong-Macau Greater Bay Area, Goal, Research, MIM, Faculty, Tutoring, Medicine

This year, HKBU is the only Hong Kong institution represented in the MiM ranking.

Key Points: 
  • This year, HKBU is the only Hong Kong institution represented in the MiM ranking.
  • The Financial Times MiM ranking analysed top management programmes across the world based on factors including school diversity, alumni career progression, and international experience and research.
  • Hong Kong Baptist University (HKBU) School of Business is among 1% of business schools worldwide with triple accreditation by: AACSB, AMBA and EQUIS.
  • Dedicated to whole-person business education, the School is among the top 25 business schools in Asia-Pacific ranked by Financial Times offering a full range of undergraduate and postgraduate programmes (Master, MBA, MSc, DBA and PhD).